Back
Citius Pharmaceuticals Vs. Cara Therapeutics Industry Stock Comparison
Sell
21
CTXR
Citius Pharmaceuticals
Last Price:
0.56
Seasonality Move:
-8.52%
Sell
11
CARA
Cara Therapeutics
Last Price:
0.30
Seasonality Move:
-11.19%
Sell
21
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.57. The Score for CTXR is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Cara Therapeutics (CARA)
is a Sell
Is Cara Therapeutics a Buy, Sell or Hold?
- The current Cara Therapeutics [CARA] share price is $0.29. The Score for CARA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- CARA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
CARA Stock Price Chart
What is Cara Therapeutics's stock price today?
-
The Cara Therapeutics share price today is $0.29
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CARA is experiencing selling pressure, which indicates risk of future bearish movement.
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 47.64 | Sell |
| Chaikin Money Flow: | 1049687 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.52 - 0.6) | Buy |
| Bollinger Bands (100): | (0.55 - 0.81) | Sell |
CARA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 43.76 | Sell |
| Chaikin Money Flow: | -366348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.29 - 0.35) | Sell |
| Bollinger Bands (100): | (0.26 - 0.64) | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.53 | Buy |
| 20-day SMA: | 0.55 | Buy |
| 50-day SMA: | 0.7 | Sell |
| 200-day SMA: | 0.72 | Sell |
| 8-day EMA: | 0.54 | Buy |
| 20-day EMA: | 0.56 | Buy |
| 50-day EMA: | 0.63 | Sell |
| 200-day EMA: | 0.73 | Sell |
CARA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.28 | Buy |
| 20-day SMA: | 0.31 | Sell |
| 50-day SMA: | 0.33 | Sell |
| 200-day SMA: | 0.61 | Sell |
| 8-day EMA: | 0.29 | Buy |
| 20-day EMA: | 0.31 | Sell |
| 50-day EMA: | 0.35 | Sell |
| 200-day EMA: | 0.92 | Sell |
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, an increase next quarter of $0.10 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Cara Therapeutics Earnings Growth & CARA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.52 per share.
Citius Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cara Therapeutics Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||